Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

VPA-985 useful in hyponatremia

May 25, 2000

Therapeutic and marketing potential expand for Cystistat

May 25, 2000

Two new series of PDE5 inhibitors claimed by Pfizer

May 19, 2000

New class of peptides useful as selective alpha1-adrenoceptor antagonists

May 18, 2000

FDA requests additional animal data for Vasomax

May 18, 2000

HCT-1026 enters phase II trials for overactive bladder

May 15, 2000

Tanabe Seiyaku patents new inhibitors of PDE5

May 15, 2000

Fujisawa's new oxazole compounds particularly useful for glomerulonephritis

May 15, 2000

Sanofi-Synthelabo designs new PDE5 inhibitors, as reported in recent patent

May 12, 2000

A-204176 may increase IUP without cardiovascular side effects according to preclinical data

May 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.